ProMIS Neurosciences annual total assets
2021
2022
2023
2024
2025
ProMIS Neurosciences Total Assets Growth & History (PMN)
ProMIS Neurosciences's total assets was $9.2M for fiscal 2025.
View full ProMIS Neurosciences company overviewProMIS Neurosciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.2M | −$9.7M | −51.45% |
| 2024 | 2024-12-31 | $18.9M | $5.3M | +38.86% |
| 2023 | 2023-12-31 | $13.6M | $6.7M | +96.68% |
| 2022 | 2022-12-31 | $6.9M | −$10.8M | −60.98% |
| 2021 | 2021-12-31 | $17.7M | — | — |
ProMIS Neurosciences quarterly total assets
Q4.21
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $56.7M | $47.2M | +496.18% |
| Q1 2026 | 2026-03-31 | $67.4M | $53.8M | +393.98% |
| Q4 2025 | 2025-12-31 | $9.2M | −$9.7M | −51.45% |
| Q3 2025 | 2025-09-30 | $21.5M | −$3.1M | −12.45% |
| Q2 2025 | 2025-06-30 | $9.5M | $8.1M | +574.63% |
| Q1 2025 | 2025-03-31 | $13.6M | $10.1M | +284.60% |
| Q4 2024 | 2024-12-31 | $18.9M | $5.3M | +38.86% |
| Q3 2024 | 2024-09-30 | $24.5M | $6.6M | +37.11% |
| Q2 2024 | 2024-06-30 | $1.4M | −$88,471 | −5.91% |
| Q1 2024 | 2024-03-31 | $3.5M | −$879,974 | −19.87% |
| Q4 2023 | 2023-12-31 | $13.6M | $6.7M | +96.68% |
| Q3 2023 | 2023-09-30 | $17.9M | $12.5M | +232.16% |
| Q2 2023 | 2023-06-30 | $1.5M | −$8.7M | −85.30% |
| Q1 2023 | 2023-03-31 | $4.4M | — | — |
| Q4 2022 | 2022-12-31 | $6.9M | −$10.8M | −60.98% |
| Q3 2022 | 2022-09-30 | $5.4M | — | — |
| Q2 2022 | 2022-06-30 | $10.2M | — | — |
| Q4 2021 | 2021-12-31 | $17.7M | — | — |
ProMIS Neurosciences total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, ProMIS Neurosciences's total assets decreased from $17.7M to $9.2M, a change of −$8.6M. The latest reported quarter, Q2 2026, shows $56.7M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ProMIS Neurosciences source filings ↗